UCB Seeks 2 Billion-Euro Loan to Refinance Schwarz Pharma Debt (Bloomberg)
Nov. twenty-five (Bloomberg) — UCB SA, Belgium’s greatest drugmaker by sales, skeleton to get 2 billion euros ($3 billion) of loans to refinance debt used to buy Germany’s Schwarz Pharma AG.